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An effective immune response leads to rapid elimination of infectious agents, with seemingly little
long-term impairment to the host. New findings by Morais da Fonseca et al. reveal that acute infec-
tions may result in permanent disruption of tissue homeostasis and immune dysfunction, long after
clearance of a pathogen.Throughout the course of one’s lifetime,
an individual will experience numerous
episodes of acute and chronic microbial
infection—including, but not limited to,
gastrointestinal and respiratory infec-
tions. Exposure to certain pathogens has
been shown to have profound, long-last-
ing consequences on the function of
the host immune responses (Medzhitov,
2008, 2010), with some chronic infections
proposed as triggers for inflammatory
disorders such as multiple sclerosis,
lupus, and inflammatory bowel disease
(IBD) (Karin et al., 2006; Wucherpfennig,
2001). In contrast, acute infections are
typically considered self-limiting without
engendering long-term immune conse-
quences to the host, though resolution
nevertheless requires an inflammatory
response and disruption of tissue homeo-
stasis. In this issue of Cell, Morais da
Fonseca et al. reveal that a single acute
infection with the enteric pathogen Yersi-
nia pseudotuberculosis results in a per-
manent dysregulation of tissue-specific
immunity (Morais da Fonseca et al.,
2015). Long after clearance of Yersinia,
the infection appears to cause persistent
impairment of the lymphatic network,
disrupting molecular and cellular interac-
tions between the gut and mesenteric
lymph nodes (MLN), resulting in impaired
mucosal immune responses (Figure 1).
This exciting new study reveals that acute
infections may contribute to long-term
disruption of tissue homeostasis, pro-
moting chronic immune dysfunction and
disease.
While most interactions between mi-
crobes and animals are symbiotic in
nature, the immune system has been
shaped by an evolutionary ‘‘arms race’’
with pathogens. Examples of chronic in-
fections resulting in persistent inflamma-tion and localized tissue damage include
Mycobacterium tuberculosis (tubercu-
losis), Helicobacter pylori (peptic ulcers
and gastric cancer), hepatitis B virus and
hepatitis C virus (chronic hepatitis and
cirrhosis), and Borrelia burgdorferi (Lyme
disease) (Karin et al., 2006; Wucherpfen-
nig, 2001). However, there are fewer ex-
amples illustrating how acute infections
may be linked to permanent alterations
to host immunity. Rheumatic fever, an in-
flammatory disease involving the heart
and joints, develops following an acute,
self-limiting infection of the pharynx with
group A Streptococcus pyogenes. A
pathological consequence of molecular
mimicry, the immune response to strepto-
coccal M protein elicits cross-reactivity to
human protein antigens, specifically
myosin, tropomyosin, and laminin in car-
diac myocytes. However, whether acute
infections permanently alter general im-
mune function has remained unclear, as
has evidence that a pathogen can trigger
chronic inflammatory diseases after its
clearance by the immune system. Here,
Morais da Fonseca et al. report that
after an acute gastrointestinal infection
with Y. pseudotuberculosis, 70% of mice
develop chronic mesenteric lymphade-
nopathy (CL+) despite clearance of Yersi-
nia. In a series of elegant experiments, the
authors reveal that infection-induced tis-
sue damage and remodeling of mesen-
teric lymphoid tissues promotes impaired
integrity of the lymphatic network, as
shown by leakage of fluorescent BODIPY
from lymphatic vessels into the surround-
ing mesenteric adipose tissue (MAT). As
a result of increased lymphatic perme-
ability, migratory CD103+CD11b+ DCs
were shown to accumulate in the MAT
compartment rather than transiting to
MLNs as expected (Figure 1), therebyCell 16blunting robust mucosal immune re-
sponses. Notably, the defect in lymphatic
integrity persisted at least nine months
post-Yersinia infection, suggesting dura-
ble pathologic consequences well after
clearance of the pathogen. A similar
finding was previously reported where
respiratory tract infection with Myco-
plasma pulmonis led to persistent lym-
phangiogenesis and reduced transport
of antigen presenting cells from the air-
ways to draining lymph nodes (Baluk
et al., 2005). Morais da Fonseca and co-
workers extend these previous concepts
to reveal a mechanism whereby tissue
damage caused during acute gastrointes-
tinal infection impairs proper mucosal
immune function. Specifically, pathogen-
induced reduction in trafficking of migra-
tory gut DCs to the MLN compromises
the ability of these cells to promote oral
tolerance and protective immunity to oral
vaccination.
The authors proceed to show that
the microbiota is required to sustain
inflammation after resolution of Yersinia.
Germ-free (GF) mice infected with
Y. pseudotuberculosis developed lymph-
adenopathy, similar to specific-pathogen
free (SPF) mice. However, migration dy-
namics of CD103+CD11b+ DCs from the
lamina propria to MLNs remained unaf-
fected in GF mice, suggesting that Yersi-
nia infection causes mislocalization of
DCs to the MAT via effects on the micro-
biota. Antibiotic treatment depleting the
microbiota in SPF mice was sufficient to
reduce cell infiltration into the surrounding
MAT, restoring proper DC trafficking
and robust mucosal immunity, further
implicating the microbiota as a vehicle
for sustained immune dysregulation
following resolution of acute infection. It
is important to note, however, that the3, October 8, 2015 ª2015 Elsevier Inc. 271
Figure 1. Proposed Model for Durable Inflammatory Responses Following Acute Infection
Under normal conditions (left), migratory CD103+ CD11b+ DCs recognize and internalize antigens from the
gut and traffic to MLNs via lymphatic vessels. In the MLNs, CD103+ CD11b+ DCs induce TREG and TH17
responses to promote oral tolerance and protective immunity to oral vaccination. Following the clearance
of Yersinia pseudotuberculosis (right), infection-induced tissue damage leads to increased permeability of
the lymphatic network. As a result, migratory DCs accumulate in the MAT compartments rather than
trafficking to MLNs, blunting TREG and TH17 responses. The microbiota sustains inflammation following
clearance of Yersinia, as enhanced exposure to microbial ligands occur due to increased permeability of
the lymphatic system. MLN, mesenteric lymph nodes; MAT, mesenteric adipose tissues.development of chronic lymphadenopa-
thy was not associated with either a
bloom of pathogenic bacterial strains
(pathobionts) or dysbiosis of the gut mi-
crobiota, as lymphadenopathy was not
transmissible via co-housing or fecal
transplant into uninfected GF mice.
Rather, it was likely due to enhanced
exposure of the immune system to gut mi-
crobial ligands as a result of defective
lymphatic integrity, as treatment with bac-
terial products alone was able to promote
and sustain inflammation following enteric
infection.
As features of chronic inflammatory dis-
eases typically mirror immune responses
to acute infection, identification of a direct
link between a causal infectious agent and
chronic disease has been challenging. For
Crohn’s disease, a chronic inflammatory
condition of the gastrointestinal tract,
many, including Crohn and colleagues,
have postulated an inciting infectious272 Cell 163, October 8, 2015 ª2015 Elsevieagent may be responsible for the initiation
of disease (Crohn et al., 1984; Hugot et al.,
2003; Sartor, 2005). Despite extensive
research efforts, a causative organism(s)
for Crohn’s disease has yet to be repro-
ducibly validated, though this issue re-
mains controversial (Greenstein, 2003).
Perhaps chronic inflammation observed
in Crohn’s patients may be the result of
persistent effects of a previously encoun-
tered infection that caused a long-lasting
impairment of the immune system. The
study by Morais da Fonseca et al. pro-
vides a novel framework to examine how
a cleared infection may induce permanent
tissue remodeling and altered immune re-
sponses, contributing to chronic disease
later in life. However, outstanding ques-
tions remain despite these comprehensive
advances; namely the mechanism by
which Yersinia promotes chronic lymph-
adenopathy remains unresolved. What
cellular and molecular changes to ther Inc.host impair integrity of lymphatic vessels?
Are there specific bacterial factors that are
required for this outcome? Further, it is un-
known why certain populations of mice
undergo lymphatic remodeling, whereas
others (cage mates) are protected from
lymphadenopathy. Not surprisingly, the
outcomes uncovered by this new study
are unlikely to be specific to Yersinia path-
ogenesis as the authors showed Toxo-
plasma gondii infection, as well as T cell
transfer of colitis, are both sufficient to
promote chronic lymphadenophathy.
These data suggest that chronic inflam-
matory diseases may be caused by acute
infections and are a consequence of a
generalized host response. Collectively,
the innovative findings from Morais da
Fonseca and coworkers reveal an
intriguing hypothesis whereby remodeling
of the immune system by an acute infec-
tion may cause chronic tissue-specific
damage and symptoms associated with
IBD and autoimmunity and may help
explain a possible etiology of various idio-
pathic inflammatory conditions.REFERENCES
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